Luis H. Toledo-Pereyra
Corporate Officer/Principal at Michigan State University
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Frederick J. Schwab | M | 84 |
Michigan State University
| - |
Marcos Dantus | M | - |
Michigan State University
| - |
Thomas C. Voice | M | - |
Michigan State University
| - |
Lawrence T. Drzal | M | - |
Michigan State University
| - |
Gundel Tora Gunilla Jönson | M | 81 |
Michigan State University
| - |
Margaret E. Thompson | M | - |
Michigan State University
| - |
David Thronson | M | - |
Michigan State University
| - |
Edward J. Rothwell | M | - |
Michigan State University
| - |
Erik D. Goodman | M | - |
Michigan State University
| - |
Mary Gager-Drew | F | - |
Michigan State University
| - |
Frederick P. Morgeson | M | - |
Michigan State University
| - |
Paul Jaques | M | - |
Michigan State University
| 15 years |
Sandra Pierce | F | 65 |
Michigan State University
| - |
Paul Menchik | M | 76 |
Michigan State University
| 38 years |
Amit Sachdev | M | - |
Michigan State University
| 9 years |
Diane Ebert-May | F | - |
Michigan State University
| - |
Holly Rosen | F | - |
Michigan State University
| - |
Dolores Cook | F | - |
Michigan State University
| - |
Dave Pruder | M | - |
Michigan State University
| - |
Dennis Martell | M | - |
Michigan State University
| - |
Marilyn Tarrant | F | - |
Michigan State University
| - |
David Weismantel | M | - |
Michigan State University
| - |
Anna Moore | M | - |
Michigan State University
| 6 years |
Stephanie DeMeester | F | - |
Michigan State University
| - |
Carl E. Liedholm | M | 83 |
Michigan State University
| 59 years |
Celeste Clark | M | 71 |
Michigan State University
| 12 years |
Fredric D. Frank | M | - |
Michigan State University
| - |
Louis Weckstein | M | 87 |
Michigan State University
| - |
Ramani Narayan | M | 75 |
Michigan State University
| - |
Thomas D. Ogden | M | 75 |
Michigan State University
| - |
M. Peter McPherson | M | 83 |
Michigan State University
| - |
Percy A. Pierre | M | 85 |
Michigan State University
| 34 years |
Elizabeth Chappell | F | 66 |
Michigan State University
| - |
Joel I. Ferguson | M | 84 |
Michigan State University
| 32 years |
Koon Shum Choi | M | 66 |
Michigan State University
| - |
Ian Ross | M | - |
Michigan State University
| - |
Barbara A. Given | M | - |
Michigan State University
| - |
Jeffrey W. Potts | M | - |
Michigan State University
| - |
Marvin H. McKinney | M | - |
Michigan State University
| - |
Michael S. Mazzola | M | - |
Michigan State University
| 31 years |
James G. Agee | M | - |
Michigan State University
| - |
Clifton E. Haley | M | - |
Michigan State University
| 23 years |
George Rowan | M | - |
Michigan State University
| - |
Robert Doud | M | - |
Michigan State University
| - |
Tim A. Fischell | M | - |
Michigan State University
| - |
Richard D. McLellan | M | 81 |
Michigan State University
| - |
Elliot A. Spoon | M | 73 |
Michigan State University
| 23 years |
Thomas G. Coon | M | - |
Michigan State University
| - |
Jose Bernardo Cibelli | M | - |
Michigan State University
| - |
Zhinong Yan | M | - |
Michigan State University
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paul Okimoto | M | 88 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 11 years |
George Tsukuda | M | - |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Larry McCleary | M | 73 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 4 years |
Robert E. Strom | M | - |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Rachmat M. Umar | M | - |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
David Winter | M | 89 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 4 years |
Frank J. Drechsler | M | 57 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 57 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Luis H. Toledo-Pereyra
- Personal Network